Objective To study the threshold effect of export trade on internal and external R&D investment in China’s pharmaceutical industry,and to provide reference for some pharmaceutical enterprises to improve the inves...Objective To study the threshold effect of export trade on internal and external R&D investment in China’s pharmaceutical industry,and to provide reference for some pharmaceutical enterprises to improve the investment.Methods The panel data of pharmaceutical industry in 25 provinces and cities in China from 2009 to 2019 were selected to conduct empirical analysis by establishing a threshold regression model,and a better export trade interval was obtained.Results and Conclusion There is a threshold value for the effect of new product export on both internal and external R&D expenditures,and the threshold values are 845.2788 million yuan and 318.4198 million yuan,respectively.There is a single threshold effect of export trade on both internal and external R&D investment in China’s pharmaceutical industry,and the effect of export trade on internal and external R&D investment changes from negative to positive as the export trade develops from low to high.展开更多
This paper study argues that some disruptive new trends are surfacing with the emergence of new technologies,which makes an efficient and effective R&D and innovation system even more relevant for any country to c...This paper study argues that some disruptive new trends are surfacing with the emergence of new technologies,which makes an efficient and effective R&D and innovation system even more relevant for any country to compete at a global level.Against this backdrop,the study tries to measure the effectiveness of the Chinese innovation system,using the“R&D spending as percentage of GDP”as the input variable and the“contribution of R&D and related business activities to the value‐added manufacturing exports”as the output variable.Based on a 59‐country sample in the OECD‐WTO TiVA database,the regression results show a significant and positive correlation between the two variables.The findings also complement with other existing empirical and qualitative studies in this area.The overall findings show that China has achieved significant efficiency and effectiveness in its innovation system compared with many other countries;in fact,since 2009,the efficiency has accelerated.However,it still lags behind the major global players.This means China still has some room to improve in order to transform its increasing inputs in R&D and technology innovation into commensurate outputs.This situation calls for further improvements in its innovation ecosystem.展开更多
基金Research on Innovation and Development Strategy of Pharmaceutical Industry in Liaoning Province(2020lslktyb-095).
文摘Objective To study the threshold effect of export trade on internal and external R&D investment in China’s pharmaceutical industry,and to provide reference for some pharmaceutical enterprises to improve the investment.Methods The panel data of pharmaceutical industry in 25 provinces and cities in China from 2009 to 2019 were selected to conduct empirical analysis by establishing a threshold regression model,and a better export trade interval was obtained.Results and Conclusion There is a threshold value for the effect of new product export on both internal and external R&D expenditures,and the threshold values are 845.2788 million yuan and 318.4198 million yuan,respectively.There is a single threshold effect of export trade on both internal and external R&D investment in China’s pharmaceutical industry,and the effect of export trade on internal and external R&D investment changes from negative to positive as the export trade develops from low to high.
基金This research benefited from the support of the“China‐Africa Comparative Study of Agricultural Public Policy and Rural Poverty”Project,financed by the China National Science Foundation(CNSF)(Project ID:71261140371)。
文摘This paper study argues that some disruptive new trends are surfacing with the emergence of new technologies,which makes an efficient and effective R&D and innovation system even more relevant for any country to compete at a global level.Against this backdrop,the study tries to measure the effectiveness of the Chinese innovation system,using the“R&D spending as percentage of GDP”as the input variable and the“contribution of R&D and related business activities to the value‐added manufacturing exports”as the output variable.Based on a 59‐country sample in the OECD‐WTO TiVA database,the regression results show a significant and positive correlation between the two variables.The findings also complement with other existing empirical and qualitative studies in this area.The overall findings show that China has achieved significant efficiency and effectiveness in its innovation system compared with many other countries;in fact,since 2009,the efficiency has accelerated.However,it still lags behind the major global players.This means China still has some room to improve in order to transform its increasing inputs in R&D and technology innovation into commensurate outputs.This situation calls for further improvements in its innovation ecosystem.
